Biodesix Reports Strong 2025 Growth Ahead of Investor Roadshow
Biodesix reports 24% full-year 2025 revenue growth to $88.5M, with Q4 surging 41% YoY. Company expects adjusted EBITDA positivity and plans investor roadshow.
BDSXfinancial resultsrevenue growth